Workday News
9 articles
Exploring 3 High Growth Tech Stocks in the US Market
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, is experiencing significant earnings growth, outpacing the biotech industry with a 626.8% increase over the past year. Despite trailing behind the broader U.S. market in revenue growth projections, the company is focused on expanding its operations through aggressive research and development efforts. ACADIA is committed to advancing its pipeline, with significant findings on investigational drugs like ACP-711 for essential tumor treatments and improvements in Parkinsons disease psychosis management with NUPLAZID®. These efforts underscore the companys potential for long-term innovation and competitiveness in neurology-focused therapies.
Product StageExpand
Exploring 3 High Growth Tech Stocks in the US Market
Intapp, Inc. is a company that provides AI-powered solutions, primarily generating revenue from its Software & Programming segment. With a market cap of $3.36 billion, Intapp is on a path to profitability within three years, with an anticipated annual earnings growth of 107.61%. The companys strategic focus on AI technology is highlighted by its recent adoption by Infinedi Partners for the DealCloud platform, which aims to enhance operational efficiencies in the financial sector. This move diversifies Intapps client base and strengthens its position in high-growth tech sectors. The companys commitment to innovation is evident in its R&D investments, aligning expenses with long-term growth objectives.
CustomersPartners
August 2025's Stock Selections With Estimated Undervaluations
The article discusses the current volatility in the U.S. stock market and highlights undervalued stocks that may present investment opportunities. Datadog, Inc. is identified as one such company, with its current trading price significantly below its estimated fair value, suggesting potential undervaluation. Despite a decline in profit margins and net income, Datadogs revenue growth remains strong, with earnings forecasted to grow at 34.2% annually, outpacing the broader market. This positions Datadog for a potentially positive growth outlook. The article also mentions Workday, Inc. as another undervalued stock with strong revenue growth, despite declining profit margins.
High Growth US Tech Stocks To Watch In August 2025
aTyr Pharma, Inc., a clinical-stage biotechnology company, is focused on developing therapies for fibrosis and inflammation. Despite being unprofitable with modest revenue, the company is on a high-growth trajectory, with anticipated annual revenue increases of 64.4%, significantly above the U.S. market average. aTyr Pharma is heavily investing in R&D, particularly in its EFZO-FIT study for pulmonary sarcoidosis treatments. Recent filings for substantial shelf registrations indicate a strategic move to bolster capital for research and commercialization, positioning the company as a promising player in biotech innovation.
Product StageInvestment
The HR tech giant said it had no indication of any unauthorized access to customer systems, but has not ruled out a breach affecting customers' personal information.
Workday, a major provider of HR technology, has experienced a data breach involving a third-party customer relationship database. Hackers accessed personal information, including names, email addresses, and phone numbers. While Workday stated there was no indication of access to customer tenants or their data, the stolen information could be used for social engineering scams. The breach is part of a series of cyberattacks targeting Salesforce-hosted databases, affecting companies like Google and Cisco. The breach was discovered on August 6, and Workdays blog post about the incident is hidden from search engines, raising questions about transparency.
3 Growth Companies Insiders Are Betting On
Liquidia Corporation, a biopharmaceutical company with a market cap of $2.22 billion, is experiencing significant growth prospects. The company recently received FDA approval for YUTREPIA, an inhalation powder for pulmonary arterial hypertension, marking a crucial milestone. Despite ongoing patent litigation with United Therapeutics, Liquidia is poised for substantial revenue growth, forecasted at 43.8% annually. The companys shares are trading below their estimated fair value, with profitability anticipated within three years. Insider ownership stands at 11%, indicating confidence in the companys future potential.
FDA approved/pending approval
CyberArk to Report Q1 Earnings: Is a Beat in Store for the Stock?
CyberArk Software Ltd. is expected to exceed expectations for its first-quarter 2025 earnings report, scheduled for May 13. The company anticipates non-GAAP earnings per share between 74-81 cents, with a consensus estimate of 79 cents, indicating a 5.3% year-over-year decline. However, revenue is projected to grow by 39% year-over-year, driven by increased demand for cybersecurity solutions, particularly in privileged access management. CyberArks shift to a software-as-a-service and subscription-based model is expected to bolster revenue growth, with subscription revenues estimated to rise by 54.1%. Despite strong demand, the company faces challenges from slower IT spending and broader macroeconomic uncertainties.
Workday Stock Gets Relative Strength Rating Bump
The article discusses a recent upgrade in the Relative Strength Rating for Workday, indicating an improvement in its technical stock performance. This upgrade suggests a positive outlook for the companys stock, though it remains to be seen if this trend will continue. The article is brief and focuses on the stock market performance aspect of Workday.
חברת Workday האמריקאית רוכשת את HiredScore במאות מיליוני דולרים | כלכליסט
Workday, a leading American HR technology company, has acquired HiredScore, an AI-driven company with a significant development center in Israel. The acquisition, estimated to be worth hundreds of millions of dollars, marks Workdays first purchase in Israel. HiredScore, founded in March 2013 and led by Athena Karp, employs over 150 people, primarily in Tel Aviv. The acquisition aims to enhance Workdays portfolio with AI solutions that provide real business value, focusing on talent optimization and HR transformation. HiredScore was previously self-funded by the Karp family, known for their real estate empire in the U.S. The acquisition aligns with Workdays strategy to offer innovative solutions in the evolving HR landscape.
Acquisition